Key Highlights
- Julie Dewey appointed Chief Investor Relations and Communications Officer.
- Max Reinhardt starts as President of Global Spine.
- Dewey and Reinhardt to join Orthofix’s Executive Leadership Team.
- Dewey brings over 25 years of experience in investor relations.
- Performance-based and time-based stock options granted as inducements.
Source: Business Wire
Notable Quotes
- “I am thrilled to join Orthofix in this new leadership role at such a transformational time in its growth trajectory. I look forward to working with Massimo and the rest of the Orthofix team to execute on the company’s growth strategy and deliver a best-in-class experience for the investment community and key stakeholders.” — Julie Dewey, Chief Investor Relations and Communications Officer at Orthofix Medical Inc
- “We are excited to welcome Julie to the company. She is deeply respected within the industry and brings with her vast knowledge of our markets, technologies, and growth strategies.” — Massimo Calafiore, President and CEO at Orthofix Medical
SoHC's Take
Orthofix Medical’s strategic appointments of Julie Dewey and Max Reinhardt signify a robust effort to bolster its executive leadership team amid a period of transformative growth. Dewey’s extensive background in investor relations and corporate communications positions her as a vital asset in enhancing the company’s market presence and stakeholder engagement. Reinhardt’s leadership of the global spine business is expected to drive innovation and expansion in this critical segment. The performance-based and time-based stock options offered as inducements reflect Orthofix’s commitment to aligning executive incentives with shareholder value creation. Overall, these appointments underscore Orthofix’s dedication to strengthening its leadership and achieving sustainable growth.
